Clinical study to evaluate the efficacy and safety of LH-RH agonist alternative therapy on prostate cancer patients who relapsed after combined androgen blockade.
Phase 2
Recruiting
- Conditions
- Prostate cancer
- Registration Number
- JPRN-UMIN000007771
- Lead Sponsor
- Department of Urology, Ibaraki Prefecture Central Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients who have not observed anti-androgen withdrawal syndrome(AWS) 2)Treated with steroid drug 3)Undergone bilateral orchidectomy 4)Treated with chemotherapy 5)Treated with anti-androgen for benign prostate hyperplasia(BPH) 6)Considered inappropriate for this study by physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method